These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37556376)

  • 21. Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob.
    Treloar C; Beadman K; Beadman M; Smith KA; Christian J; Jackson AC; Tyson B; Anderson C; Smyth L; Walker M; Heslop J; Gahan G; Tawil V; Sheaves F; Maher L; Page J; Tilley D; Ryan A; Grant K; Donovan B; Stevens A; Slattery T; Pearce K; John-Leader F; Walden A; Lenton J; Crowley M; Cama E
    Harm Reduct J; 2023 Oct; 20(1):153. PubMed ID: 37864234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foot health of Aboriginal and Torres Strait Islander Peoples in regional and rural NSW, Australia.
    West M; Sadler S; Hawke F; Munteanu SE; Chuter V
    J Foot Ankle Res; 2020 May; 13(1):27. PubMed ID: 32466778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of Aboriginal and Torres Strait Islander peoples' experiences and supportive care needs associated with cancer.
    Gilroy J; Henningham M; Meehan D; Nila F; McGlone J; McAtamney A; Whittaker K; Brown B; Varlow M; Buchanan T
    BMC Public Health; 2024 Feb; 24(1):523. PubMed ID: 38378574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study.
    Lew JB; Feletto E; Worthington J; Roder D; Canuto K; Miller C; D'Onise K; Canfell K
    J Cancer Policy; 2022 Jun; 32():100325. PubMed ID: 35560263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs.
    Doyle M; Maher L; Graham S; Wand H; Iversen J
    Aust N Z J Public Health; 2018 Feb; 42(1):52-56. PubMed ID: 29168317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health workers' perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia.
    Cama E; Beadman M; Beadman K; Hopwood M; Treloar C
    Harm Reduct J; 2023 Aug; 20(1):116. PubMed ID: 37633903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system.
    Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A
    Drug Alcohol Depend; 2021 Nov; 228():109050. PubMed ID: 34607193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob program's 'cascade of care' across nine sites in New South Wales, Australia.
    Cama E; Beadman K; Beadman M; Smith KA; Christian J; Jackson AC; Tyson B; Anderson C; Smyth L; Heslop J; Gahan G; Tawil V; Sheaves F; Maher L; Page J; Tilley D; Ryan A; Grant K; Donovan B; Stevens A; Slattery T; Pearce K; John-Leader F; Walden A; Lenton J; Crowley M; Treloar C
    Harm Reduct J; 2023 Sep; 20(1):125. PubMed ID: 37670361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A complex increase in hepatitis C virus in a correctional facility: bumps in the road.
    Merone L; Ashton S; Harris A; Edwards WS; Preston-Thomas A; Gair R; Russell DB
    Aust N Z J Public Health; 2022 Jun; 46(3):377-381. PubMed ID: 35435996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of encounters related to subfertility and infertility in Australian general practice: a focus on Aboriginal and Torres Strait Islander females.
    Gilbert E; Rumbold A; Campbell S; Boyle JA; Grzeskowiak L
    BMC Womens Health; 2023 Aug; 23(1):410. PubMed ID: 37542253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving cultural safety for Australia's First Peoples: a review of the Australian Health Practitioner Regulation Agency-registered health practitioners' Codes of Conduct and Codes of Ethics.
    Milligan E; West R; Saunders V; Bialocerkowski A; Creedy D; Rowe Minniss F; Hall K; Vervoort S
    Aust Health Rev; 2021 Aug; 45(4):398-406. PubMed ID: 33844959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data analysis of zoonoses notifications in Aboriginal and Torres Strait Islander populations in Australia 1996-2021: implications for One Health.
    Riley T; Lovett R; Cumming B; Meredith A; Anderson NE; Thandrayen J
    Front Public Health; 2023; 11():1175835. PubMed ID: 37900024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia.
    Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L
    Int J Drug Policy; 2017 Sep; 47():77-85. PubMed ID: 28578863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
    Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
    J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partnering with Aboriginal and Torres Strait Islander Peoples: An Evaluation Study Protocol to Strengthen a Comprehensive Multi-Scale Evaluation Framework for Participatory Systems Modelling through Indigenous Paradigms and Methodologies.
    Lee GY; Robotham J; Song YJC; Occhipinti JA; Troy J; Hirvonen T; Feirer D; Iannelli O; Loblay V; Freebairn L; Agung-Igusti R; Chang EP; Dudgeon P; Hickie IB
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A HIV diagnosis and treatment cascade for Aboriginal and Torres Strait Islander peoples of Australia.
    Stephens JH; Gray RT; Guy R; Vickers T; Ward J
    AIDS Care; 2023 Jan; 35(1):83-90. PubMed ID: 34783623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination experienced by Aboriginal and Torres Strait Islander males in Australia: Associations with suicidal thoughts and depressive symptoms.
    Haregu T; Jorm AF; Paradies Y; Leckning B; Young JT; Armstrong G
    Aust N Z J Psychiatry; 2022 Jun; 56(6):657-666. PubMed ID: 34256631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.